Alembic JV Aleor Derma gets 1 USFDA observation for Karakhadi facility

Aleor Derma's formulation manufacturing facility located at Karakhadi, Gujarat got one observation after the completion of USFDA inspection. The inspection was carried out from 15th September 2019 to 20th September 2019.

New Delhi: Drugmaker Alembic Pharmaceuticals Ltd. (Alembic) recently informed the exchange that the United States Food and Drug Administration (USFDA) has completed inspection of its Joint Venture, Aleor Dermaceuticals Ltd.

Aleor Derma's formulation manufacturing facility located at Karakhadi, Gujarat got one observation after the completion of USFDA inspection. The inspection was carried out from 15th September 2019 to 20th September 2019.

Also Read: Alembic Pharma JV Aleor gets USFDA nod for Clobetasol Propionate ointment

Aleor Derma is a 60:40 joint venture between Alembic and Orbicular Pharmaceutical Technologies Pvt Ltd.

"Aleor Dermaceuticals (Aleor), a 60:40 Joint Venture between Alembic Pharmaceuticals (Alembic) and Orbicular Pharmaceutical Technologies (Orbicular), has completed United States Food and Drug Administration (USFDA) inspection at its formulation manufacturing facility located at Karakhadi, Gujarat, India; with one observation, " Alembic said in a filing.

Alembic Pharmaceuticals Ltd. is headquartered in Vadodara city of Gujarat. The company is involved in manufacturing of pharmaceutical products, pharmaceutical substances and intermediates. It is also termed to be a market leader in macrolides segment of anti-infective drugs in India.

Read Also: Alembic Pharma gets USFDA approval for Fenofibrate tablets to lower cholesterol